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Calcemic response to parathyroid hormone in renal failure: Role of
phosphorus and its effect on calcitriol. The calcemic response to para-
thyroid hormone (PTH) is decreased in renal failure. The reduction of
hyperphosphatemia improves the calcemic response to PTH in animals
with advanced renal failure. However, since low calcitriol levels in
renal failure may also contribute to the decreased calcemic response to
PTH, the improved calcemic response observed during the reduction of
serum phosphorus may be partially mediated by an increase in serum
calcitriol levels. The present study evaluated the calcemic response to
PTH in rats with moderate and advanced renal failure and how this
response was modified by a high and a low phosphorus diet. In addition,
the effect of a change in dietary phosphorus on calcitriol levels was also
evaluated. A 48-hour continuous infusion of 1-34 rat PTH increased the
serum calcium level to 18.2 0.4 mgldl in normal rats, versus 13.7
0.9 and 12.1 0.2 mg/dl in rats with moderate and advanced renal
failure, respectively. During the PTH infusion, a high phosphorus diet
increased the serum phosphorus and resulted in a reduced calcemic
response to PTH at each level of renal function; respective serum
calcium levels were 13.8 0.6 mg/dl in normals, 11.2 0.2 mgldl in
moderate renal failure and 9.6 0.5 mg/dl in advanced renal failure. In
normal rats and in rats with moderate renal failure, dietary phosphorus
restriction during the PTH infusion increased serum calcitriol levels. In
rats with advanced renal failure, serum calcitriol levels were lower than
in the other two groups and were not affected by changes in dietary
phosphorus. In an additional group of rats, parathyroidectomy cor-
rected the calcemic response to PTH, suggesting that resistance to the
calcemic action of PTH in renal failure requires the presence of
circulating levels of PTH. In conclusion, a decreased calcemic response
to PTH was present not only in advanced renal failure but also in
moderate renal failure. This abnormal response to PTH appears to be
multifactorial. Phosphorus restriction improved the calcemic response
to PTH and this effect could have been in part due to higher values of
calcitriol; however, in advanced renal failure, calcitriol levels were not
influenced by dietary phosphorus, and thus, the increased calcemic
response to PTH induced by phosphorus restriction was independent of
calcitriol. Finally, down regulation of bone receptors for PTH appears
to play a major role in the decreased calcemic response to PTH in renal
failure.
Resistance to the calcemic action of parathyroid hormone
(PTH) has been implicated as a factor in the development of
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both hypocalcemia and secondary hyperparathyroidism in
chronic renal failure [1]. Resistance to the calcemic action of
PTH in renal failure was first reported by Evanson in 1966 [2],
and subsequently confirmed by others in both acute and chronic
renal failure [3—5]. However, the mechanism(s) responsible for
the resistance to the calcemic action of PTH have been dis-
puted. Postulated mechanisms include: 1) phosphate retention
[6]; 2) decreased serum levels of vitamin D metabolites [7]; and
3) down regulation of bone cell receptors for PTH due to high
serum PTH levels [8].
Studies in uremic rats by Somerville and Kaye have shown
that an increase in serum phosphorus produced skeletal resis-
tance to the calcemic action of PTH [6]. However, in dogs with
chronic renal failure, Kaplan et al observed that phosphate
restriction, sufficient to prevent phosphate retention, did not
correct the resistance to the calcemic action of PTH [9].
Considerable evidence has accumulated both for and against
vitamin D metabolites as a factor in the skeletal resistance to
the calcemic action of PTH. Massry et al observed that cal-
citriol administration partially corrected the resistance to the
calcemic action of PTH in rats with either acute or chronic renal
failure [5]. In another study, these investigators also observed
that the administration of catcitriol together with 24,25(OH)2D3
corrected the calcemic response to PTH [7]. However, other
investigators have not been able to confirm that calcitriol
improves the calcemic response to PTH [8].
In renal failure, the relative effects of hyperphosphatemia and
low calcitriol levels on the resistance to the calcemic action of
PTH are still unclear. Since the production of calcitriol is
modulated by the serum phosphorus, the effect of phosphorus
on the calcemic response to PTH may be mediated by changes
in calcitriol levels.
In most of the previous studies in which the calcemic
response to PTH was evaluated, the infusion of PTH was for a
relatively short period of time (5 to 12 hours) and only one
factor was evaluated. In addition, only animals with advanced
renal failure were studied; thus, little information is available
about the calcemic response to PTH in moderate renal failure
and during a longer PTH infusion.
Another factor to be considered in the decreased calcemic
response to PTH is the effect of "down regulation" which
occurs as a consequence of the increase in PTH levels. In a
previous study, thyroparathyroidectomy normalized the calce-
mic response to PTH in renal failure [8].
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The goal of the present study was to evaluate: 1) if resistance
to the calcemic action of PTH was present, not only in
advanced, but also in moderate renal failure; 2) the effect of
changes in dietary phosphorus on the calcemic response to
PTH; 3) whether phosphorus induced changes in the calcemic
response to PTH could be mediated by changes in serum levels
of calcitriol; and 4) the effect of high levels of PTH on the
calcemic response to PTH in advanced renal failure.
Our findings suggest that both phosphorus and the degree of
renal failure independently affect the calcemic response to
PTH. Changes in calcitriol may partially mediate the effect of
phosphorus on the calcemic response to PTH in normal and
moderate renal failure rats. However, in advanced renal failure,
serum calcitriol levels were not influenced by changes in serum
phosphorus. Finally, the removal of circulating PTH by selec-
tive parathyroidectomy in rats with advanced renal failure
corrected the calcemic response to PTH.
Methods
Male Wistar rats weighing 125 to 140 grams were divided into
three groups: the first group underwent sham operation, the
second group ligation of one main artery in the hilum of the left
kidney, followed one week later by right nephrectomy; and the
third group, ligation of two main arteries in the hilum of the left
kidney, followed one week later, by right nephrectomy. The
intent was to produce different degrees of renal failure in the
second and third groups.
All rats were placed on a diet containing 0.6% calcium and
1.2% phosphorus with 100 IU/100 g of vitamin D. This high
phosphorus diet has been shown to exacerbate secondary
hyperparathyroidism in rats with renal failure [10, 11]. The rats
were maintained in individual cages and pair-fed. The daily food
allowance was adjusted to the intake of the lowest group;
however, rats consistently eating less than 12 grams per day
were removed from the study. Seventeen days after the initia-
tion of the high phosphorus diet, blood was obtained for
measurement of creatinine, phosphorus, calcium, and PTH.
Based on the serum creatinine concentration, rats were as-
signed to the following groups:
Normal renal function—serum creatinine less than 0.5 mg/dl;
Moderate renal failure—serum creatinine 0.5 to 0.6 mg/dl;
and
Advanced renal failure—serum creatinine greater than 0.6
mg/dl.
Twenty days after the right nephrectomy, rats were fasted for
12 hours; then rat PTH 1-34 (Bachem, Torrance, California,
USA) from a single lot was infused at a constant rate of 1.3
U/lOG g/hr for 48 hours via a subcutaneously implanted minios-
motic pump (Alza, Palo Alto, California, USA; model 2001).
The pumps were filled with PTH in isosmotic saline with 2%
cysteine and HC1 added to achieve a pH 1.5. Blood for calcium,
phosphorus and creatinine was obtained immediately before the
placement of the miniosruotic pump, and 25 and 48 hours after
the pump placement. Since measurement of calcitriol requires a
large aliquot of serum, a separate group of rats were sacrificed
before the PTH infusion and the blood used for calcitriol
measurement. Calcitriol was also measured at sacrifice after the
48 hours of PTH administration.
Since the model 2001 miniosmotic pump maintains a constant
delivery of one microliter per hour and the filling volume is 200
microliters, its functional life-span is at least seven days. Thus,
after 48 hours of infusion, each pump was removed and
implanted in a rat from a different group; as a result, the same
pump was used in a different group of rats in a random order.
Each pump was used in three rats. During the PTH infusion,
rats were housed in individual metabolic cages and urine was
collected for measurement of volume, calcium, phosphorus and
creatinine.
Effect of renal failure
To evaluate the effect of renal failure on the calcemic
response to PTH, rats with normal renal function (N = 10), rats
with moderate renal failure (N = 9) and rats with advanced
renal failure (N 13) received a PTH infusion as previously
described. To separate the effect of the magnitude of renal
failure from that of phosphorus retention, all rats received a low
phosphorus (0.2%) diet (LPD) during the PTH infusion. To
minimize intestinal absorption of calcium, the diet was calcium
free.
Effect of phosphorus retention
To evaluate the role of serum phosphorus on the calcemic
response to PTH, rats from each level of renal function under-
went a PTH infusion while receiving either an LPD or a high
phosphorus diet (1.0% P, 0% Ca) (HPD). To evaluate the effect
that changing dietary phosphorus independent of a PTH infu-
sion, may have on the serum calcium concentration, rats with
advanced renal failure were studied during the ingestion of
either a LPD (N = 7) or HPD (N = 7) for a 48 hours period;
PTH was not infused in these rats.
Changes in serum calcitriol
These were assessed by determination of serum calcitriol in
normal rats, and in rats with moderate and advanced renal
failure before and after 48 hours of PTH infusion. Serum
calcitriol was studied during both a LPD and HPD.
Effect of parathyroidectomy
To determine the role of high PTH levels on the decreased
calcemic response to PTH, rats with advanced renal failure
underwent selective parathyroidectomy (PTX) (N = 7) two
days before the infusion of PTH. To prevent a fall in serum
calcium during the two days following PTX, rats were placed on
a high calcium diet (Ca:1.3%, P:0.8%). During the PTH infu-
sion, these rats ingested a LPD.
Biochemical determinations
Serum calcium was measured by atomic absorption (Perkin
Elmer, Norwalk, Connecticut, USA), serum phosphorus with a
specific kit (Sigma, St Louis, Missouri, USA); serum creatinine
with a creatinine analyzer (Beckman Instruments, Fullerton,
California, USA) and serum PTH with an N-terminal radioim-
munoassay (Nichols Institute, San Juan Capistrano, California,
USA). This assay has been previously validated for the deter-
mination of circulating PTH in the rat [11—131. Serum levels of
calcitriol were measured using a radioreceptor assay (Nichols
Institute); the intra-assay and inter-assay coefficient of variation
were 6.8% and 8.5%, respectively. A comparison of this assay
with conventional radioreceptor assay after double column
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Fig. 1. Serum levels of PTH in the
three groups of rats: normals (Cr <
0.5 mg/dl), moderate (Cr 0.5—0.6
mgldl) and advanced renal failure
(Cr > 0.6 mg/dl). Values are mean
SE. (*) P <0.01 vs. Cr < 0.5 mg/
dl, (+) P < 0.01 vs. Cr 0.5—0.6
mg/dl.
separation showed a significant correlation approaching identity
(r = 0.93, N = 32).
Statistics
Comparisons of the means was made by ANOVA followed
by the Duncan test. The unpaired t-test was used to compare
two means of different groups. Results are expressed as mean
standard error (SE).
Results
Effect of renal failure
Rats with moderate and advanced renal failure had creatinine
clearances of 5.1 0.5 mllmin/kg and 2.5 0.2 mI/mm/kg,
respectively; these were significantly lower (P < 0.01) than 10.1
0.9 mllmin/kg in normal rats. The basal serum PTH levels in
the three groups of rats are shown in Figure 1. PTH levels were
highest in rats with advanced renal failure; in addition, the PTH
level was higher in the group with moderate renal failure than
normals.
The effect of a 48-hour PTH infusion on serum calcium and
phosphorus is shown in Figure 2. During the PTH infusion, rats
were maintained on a LPD. In normal rats, the PTH infusion
increased the serum calcium to 18.2 0.4 mg/dl; this value was
significantly greater than in rats with moderate (13.7 0.9
mg/dl) and advanced (12.1 0.2 mg/dl) renal failure. At
baseline, the rats with advanced renal failure had a significantly
lower serum calcium concentration (8.9 0.2 mgldl, P < 0.01)
and a significantly greater serum phosphorus concentration
(12.1 0.8 mg/dl, P < 0.01) than either normal rats or rats with
moderate renal failure. The infusion of PTH during a LPD
produced a decrease in serum phosphorus. At 24 hours, the
serum phosphorus was similar in the three groups and this was
maintained until the end of the PTH infusion (Fig. 2). As shown
in Table 1, differences in PTH-induced hypercalcemia could not
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Fig. 2. Changes in serum calcium (A) and phosphorus (B) during a 48-hour continuous PTH infusion in the three groups of rats. Values are mean
SE. (*) P < 0.05 vs. Cr <0.5 mg/dl, During the PTH infusion, rats were ingesting a low phosphorus diet.
Time, hours
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Table 1. Daily urinary excretion of calcium (mg), in rats with different levels of serum creatinine (Sc,.) during a 48 hour infusion of PTH and
receiving a low phosphorus diet (LPD; P = 0.2%, Ca = 0%) or a high phosphorus diet (HPD; P = 1.0%, Ca = 0%)
LPD HPD
Scr mg/dl <0.5 0.5—0.6 >0,5 <0.5 0.5—0,6 >0.6
24 hr 1.1 Ø3 1.4 0.4 0.8 o.r 0.1 0.03 0.4 0.1 0.3 0.06
48 hr 7.5 2.2a 2.9 Q,4 2.0 0.4a 1.6 0.6 0.9 0.2 0.8 0.20
N 10 9 13 12 10 13
N, number of rats in each group.
a P < 0,05 as compared with HPD
C Cr>0.6 *
*
____.__.____
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Fig. 3. Changes in serum calciu,n and
phosphorus during a 48-hour continuous
PTH infusion in the three groups of rats
studied: (A) normals (Cr < 0.5 mg/dl), (B)
moderate rena/failure (Cr = 0.5—0.6 mgI
dl), and (C) advanced rena/failure (Cr>
0.6 mg/dl). Continuous line (—) indicates
ingestion of a low phosphorus diet and the
dotted line (---) ingestion of a high
phosphorus diet during the PTH infusion.
Values are mean SE, (*) P < 0.05 vs.
high phosphorus diet.
be attributed to changes in urinary calcium excretion. Normal
rats, which had the greatest hypercalcemic response to PTH,
excreted more calcium in a 24 hour urine than rats with
moderate or advanced renal failure.
Effect of phosphorus
Figure 3 displays the effect of a low and a high phosphorus
diet on the calcemic response to a PTH infusion. At each level
of renal function, the HPD decreased the calcemic response to
PTH.
In rats with normal renal function the serum phosphorus was
lower at 24 hours in rats on a LPD than on a HPD (5.4 0.5 vs.
7.7 0.3 mg/dl, P < 0.01). At 48 hours, the serum phosphorus
levels were similar on a LPD or HPD (7.2 0.9 and 7.5 0.4
mg/dl, respectively). Despite similar serum phosphorus concen-
tration at 48 hours, the calcemic response to PTH was de-
creased in rats ingesting the HPD. The respective serum
calcium levels in normal rats were 13.8 0.6 vs. 18,2 0.4
mg/dl (P < 0.001) at 48 hours.
In rats with moderate renal failure on a HPD the serum
phosphorus concentration was greater than in rats on a LPD
(Fig. 3). Similar to normal rats, the HPD decreased the calcemic
response to PTH. On a HPD, the serum calcium increased to
10.4 0.2 mg/dl at 24 hours; this was marginally different than
that of rats on a LPD, 11.1 0.3 mg/dl (P = 0.07); however, by
48 hours, the serum calcium level was significantly lower on a
HPD, 11,2 0.2 mg/dl, than on a LPD, 13.7 0.9 mgldl (P <
0.01).
In rats with advanced renal failure, the serum phosphorus
level in the rats ingesting a HPD was 13.9 1.7 and 12.9 1.4
mgldl at 24 and 48 hours, respectively; on a LPD, serum
phosphorus levels were significantly lower (6.1 0.3 and 6.8
0.4 mg/dl) at 24 and 48 hours, respectively (P < 0.01). As
compared with the LPD, the calcemic response to PTH at 48
hours was decreased on an HPD, 12.0 0.2 versus 9.6 0.5
mg/dl (P < 0.001).
In rats with advanced renal failure, the change in serum
calcium, phosphorus, and calcitriol levels induced by a HPD
and a LPD during the presence or absence of a PTH infusion is
shown in Figure 4. During a LPD, a PTH infusion increased the
magnitude of the increment in serum calcium from 1.44 0.60
to 3.26 0.41 mg/dl, P < 0.01; this was associated with a
decrease (P < 0.01) in serum phosphorus that was similar in
both groups. On a HPD, the PTH infusion did not produce
significant changes in serum calcium or phosphorus. Serum
calcitriol levels were unaffected by changes in dietary phospho-
rus and the infusion of ?TH.
For all three groups, the total amount of calcium excreted in
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Fig. 4. Changes in serum calcium and phosphorus, and concentration
of serum calcitriol in rats with advanced renal failure after 48 hours
ingesting a low (LPD) or a high (HPD) phosphorus diet, with ()or
without () administration of PTH. N = 7 in each of the two LPD
groups and 13 in each of the HPD groups. Values are mean SE and (*)
P <0.01.
the urine during the PTH infusion was significantly greater in
rats ingesting a LPD than in those on a HPD (Table 1). This
reflected the differences in the serum calcium concentrations.
The amount of phosphorus excreted in the urine was increased
in rats ingesting a HPD (Table 2). For a given diet, urinary
excretion of phosphorus decreased with the severity of renal
failure.
Changes in serum calcitriol
Serum levels of calcitriol before and after the PTH infusion
are shown in Figure 5; renal failure resulted in a progressive
decrease in calcitriol levels (P < 0.01). In normal rats, the PTH
infusion increased calcitriol levels and this response was aug-
mented by the low phosphorus diet despite no significant
decrease in serum phosphorus at 48 hours. In rats with moder-
ate renal failure, the PTH infusion did not increase calcitriol
levels during the HPD, but there was a significant increase on
the LPD. In this group, the differences in dietary phosphorus
resulted in significant differences in serum levels of calcitriol
(121 25 pglml on HPD vs. 198 22 pg/mI on LPD, P < 0.05).
In rats with advanced renal failure, serum levels of calcitriol
were lowest and did not increase significantly after the PTH
infusion irrespective of the phosphorus content of the diet (72
20 pg/mI on HPD vs. 64 19 pg/ml on LPD). Those values were
not different from calcitriol levels obtained in rats with ad-
vanced renal failure on a HPD or a LPD for 48 hours without a
PTH infusion, 78 35 and 82 29 pg/mI, respectively (Fig. 4).
Effect of parathyroidectomy
In PTX rats with advanced renal failure on an LPD, PTH
infusion increased the serum calcium from 8.10 0.61 to 16.0
0.89 mg/dl, P < 0.001. The mean increase in serum calcium in
these rats (7.88 0.50 mg/dl) was similar to the increase (8.69
0.34 mg/dl) in normal rats after a PTH infusion and on a LPD
(Fig. 6). By contrast, in rats with advanced renal failure and
secondary hyperparathyroidism, the PTH infusion produced an
increase in serum calcium of only 3.10 0.24 mg/dl; this was
significantly less (P <0.01) than PTX rats with the same degree
of renal failure.
After the PTH infusion, the serum phosphorus level in PTX
rats with advanced renal failure was 7.3 0.7 mg/dl. This
concentration was similar to the post-PTH infusion in normal
rats, 7.2 0.9 mgldl, and in parathyroid-intact rats with
advanced renal failure (6.5 0.3 mg/dl).
Discussion
The results of this study show that the calcemic response to
PTH was decreased in renal failure. The degree of renal failure
and the level of serum phosphorus were factors that indepen-
dently modified the calcemic response to PTH. Moreover, this
study demonstrates that a decreased calcemic response to a 48
hour infusion of PTH was present at moderate renal failure. In
normal rats, a change in dietary phosphorus was an important
factor in the calcemic response to PTH, even without concom-
itant changes in serum phosphorus. In normal rats and in rats
with moderate renal failure, dietary phosphorus restriction
increased serum calcitriol levels which may have contributed to
the improved calcemic response to PTH. However, in ad-
vanced renal failure, the effect of phosphorus was independent
of calcitriol. In these rats, the removal of circulating PTH by
parathyroidectomy corrected the calcemic response to PTH.
Effect of renal failure
Renal failure resulted in a progressive increase in PTH and a
decrease in the calcemic response to PTH. These findings are in
agreement with previous observations that hyperparathyroid-
ism is present even in early renal failure [14—16]. As compared
with normal rats, rats with moderate and advanced renal failure
had a decreased calcemic response to PTH. Despite a LPD and
similar serum phosphorus levels, rats with moderate and ad-
vanced renal failure had less urinary excretion of phosphorus
than normal rats. Thus, it is likely that phosphorus retention
was in part responsible for the decreased calcemic response to
PTH in rats with renal failure.
Effect of parathyroidectomy
An important factor responsible for the impaired calcemic
response to PTH appears to be down regulation of bone cell
receptors due to high PTH levels [8]. Thus, the highest PTH
levels observed in rats with advanced renal failure may have
contributed to the greatest impairment in the calcemic response
to PTH. This is suggested by the fact that removal of circulating
PTH by PTX corrected the calcemic response. In a previous
study we have shown that after parathyroidectomy, the calce-
mic response to PTH was similar at any level of renal function
[17]. The correction of the calcemic response to PTH after PTX
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Table 2. Daily urinary excretion of phosphorus (mg), in rats with different levels of serum creatinine (Sr) during a 48 hour infusion of PTH
and receiving a low phosphorus diet (LPD; P = 0.2%, Ca = 0%); or a high phosphorus diet (HPD; P = 1.0%, Ca = 0%)
Scr mgldl
LPD HPD
<0.5 0.5—0.6 >0.6 <0.5 0.5—0,6 >0.6
24 hr 35 4 32 4 31 12 104 8 122 12 81 8al
48 hr 32 4 19 2 16 2 173 10 136 8 106 6a,b
N 10 9 13 12 10 13
N, number of rats in each group.
a P < 0.05 as compared with S, <0.5 on the same diet
' P < 0.05 as compared with Sr 0.5—0.6 on the same diet
500
400
n. 300
0
4-
a
200
'TOO
0
Cr <0.5 mg/dI Cr 0.5-0.6 mgldl Cr> 0.6 mg/dI
Fig. 5. Serum calcitriol levels in the
three groups of rats before (Pre-
PTH, EJ) and after (Post-PTH) a
48-hour PTH infusion during the
ingestion of either a high (HPD,
or a low phosphorus diet
(LPD, U). Values are mean SE,
(+) P < 0.05 vs. Pre.PTH, (*) P <
0,05 vs. Post-PTH-HPD. The
number of rats (Is.) in each group is
as follows: Cr < 0,5 pre-PTH, N =
6; Cr < 0.5 post-PTH-HPD, N = 5;
Cr < 0.5 post-PTH-LPD, N = 7; Cr
0.5—0.6 pre-PTH, N = 5; Cr 0.5—0.6
post-PTH-HPD, N = 5; Cr 0.5-0.6
post-PTH-LPD, N = 6; Cr > 0.6
pre-PTH, N = 8; Cr> 0.6 post-
PTH-HPD, N = 7; Cr> 0.6 post-
PTH-LPD, N 7.
substantiates that there is a down regulation of PTH receptors
in bone cells.
Effect of phosphorus
Differences in dietary phosphorus produced significant
changes in the calcemic response to PTH. A decrease in dietary
phosphorus was associated with an increase in the calcemic
response to PTH at all three levels of renal function. In normal
rats and in rats with moderate renal failure, it is difficult to
separate a direct effect of phosphorus from an indirect effect on
calcitriol synthesis. In these rats, increases in the dietary
phosphorus intake resulted in decreased calcitriol levels. Thus,
an indirect role for phosphorus through a decrease in calcitriol
levels must be considered, especially in normal rats, since the
serum phosphorus level was not changed at the end of the PTH
infusion. However, in rats with advanced renal failure, dietary
induced changes in serum phosphorus did not modify calcitriol
levels. Thus, in this group, it would appear that the effect of
phosphorus on the calcemic response was independent of
changes in serum calcitriol.
The failure of phosphorus restriction to stimulate calcitriol in
advanced renal failure has been observed previously in humans
by Lucas et al [181 and in dogs by Lopez-Hilker et a! [191. Our
results suggest that calcitriol cannot be stimulated in rats with
advanced renal failure and secondary hyperparathyroidism
since two stimulatory factors, phosphorus restriction and a
PTH infusion, did not increase serum calcitriol levels. The lack
of stimulation in these rats could in part be due to the fact that
calcitriol was maximally stimulated by high PTH in the baseline
state before the infusion of exogenous PTH.
Even without the administration of PTH, the serum calcium
increased in rats with advanced renal failure in response to a
low phosphorus diet, This suggests that for a given PTH
concentration, the calcium released from bone is increased as
the serum phosphorus is decreased.
Our findings in regard to the effect of phosphorus on the
calcemic response to PTH are in agreement with those of
Somerville and Kaye [6], who found that the removal of
phosphorus restored the calcemic response to PTH. However,
our results differ somewhat inasmuch as a decrease in the serum
phosphorus concentration only partially reversed the impaired
calcemic response to PTH. The differences between our results
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Fig. 6. Changes in serum levels of
calcium in normal rats (Normals),
rats with renal failure and
parathyroidectomy (Cr > 0.6 mg/dl,
PTX) and rats with renal failure
without parathyroidectomy (Cr>
0.6 mgldl). Values are mean SE.(*) < 0.01.
and those of Somerville and Kaye may be due to the fact that
they used a rat model of renal failure in which thyroparathyroi-
dectomy was performed. In our study, the decrease in serum or
dietary phosphorus improved but did not correct the calcemic
response to PTH; however, parathyroidectomy corrected the
calcemic response. In the present study, a high phosphorus diet
reduced the calcemic response to PTH in rats with normal renal
function. This occurred despite a similar serum phosphorus
level at the end of the PTH infusion. During the ingestion of a
HPD, the PTH induced increment in serum calcium was dimin-
ished by almost fifty percent. One possible explanation is that
the bone compartment containing readily exchangeable calcium
may have been saturated with phosphorus reducing the avail-
ability of calcium. In in vitro studies, calcium released from the
bone of isolated perfused rats tails was reduced as the phos-
phorus content of the perfusate was increased; this occurred
despite no reduction in PTH stimulated cAMP production [201.
Furthermore, a recent in vitro study shows that the increase in
extracellular phosphate directly inhibits bone resorption by
osteoclasts [21].
An increase in the calcium-phosphorus product resulting in
calcium precipitation cannot be ruled out as a cause of the
impaired calcemic response in rats fed a high phosphorus diet.
However, the fact that the high phosphorus diet decreased the
calcemic response in normal rats despite no significant change
in serum phosphorus argues against the importance of calcium
precipitation at least in this group. A more likely possibility is
the difference in the serum calcitriol levels; both PTH and
phosphorus restriction are known to increase calcitriol produc-
tion [1, 22—27]. As compared to rats on a low phosphorus diet,
we observed that a high phosphorus diet reduced the PTH-
induced elevation of serum calcitriol levels in normal rats and in
rats with moderate renal failure. In some previous studies,
calcitriol has improved the calcemic response to PTH [5, 7];
however, this beneficial effect has only been reported in renal
failure.
In patients with moderate renal failure, Llach and Massry
observed that phosphorus restriction improved the calcemic
response to PTH [28]; this was associated with an increased
calcitriol level which may have been a factor in the improved
calcemic response to PTH. However, phosphorus restriction
also resulted in reduced PTH levels. Since high PTH levels may
down regulate bone cells receptors for PTH [7], a decrease in
PTH levels induced by phosphorus restriction may have con-
tributed to the improved calcemic response to PTH.
In conclusion, in rats with moderate and advanced renal
failure there was a decrease in the calcemic response to PTH.
This was observed only if circulating PTH was present, sug-
gesting that high PTH levels may impair the calcemic response
due to down regulation of PTH receptors in bone cells. High
dietary phosphorus increased serum phosphorus levels and at
each level of renal function, further decreased the calcemic
response to PTH. In normal rats and rats with moderate renal
failure, the effect of phosphorus on the calcemic response to
PTH may in part be due to changes in serum levels of calcitriol.
However, in advanced renal failure, calcitriol levels were not
modified by dietary phosphorus and thus, the effect of phos-
phorus on the calcemic response to PTH may be independent of
serum calcitriol levels.
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